In addition to assessment of hematoxylin and eosin (H&E) features and proliferation rate (mitotic index and Ki-67), various other markers have been proposed as helpful adjuncts in risk-stratification of CLL/SLL. This evidence concerns the gene MKI67 and B-cell chronic lymphocytic leukemia.